Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07193797 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Delirium Phenotypes and Subsequent Impairment During Transition From ICU to Hospital Wards

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Final enrollment: 247 participants (planned 189)
    • Study completion date changed from estimate of Dec 31, 2025 to Jan 31, 2026
    • Eligibility criteria expanded, about 7 words
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to learn about the disability profile during transition from ICU to hospital wards of delirium patients, including cognitive impairment, physical dysfunction and psychological disorders. The main question it aims to answer is: * What is the main rehabilitation problem during transition from ICU to hospital wards for patients who experienced ICU delirium? * Dose different phenotypes of ICU delirium shows different rehabilitation problem during ICU transition? Participants will be followed up and assessed by questionnaires after discharge from ICU to hospital wards until hospital discharge.
Trial Details
NCT Number NCT07193797
Lead Sponsor Shanghai Zhongshan Hospital
Collaborators: National Natural Science Foundation of China
Conditions
(from sponsor)		 Delirium, Post ICU Syndrome
Related terms Cognitive Dysfunction, Delirium
Enrollment 247 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov